Uncategorized

NEW YORK, Sept. 6, 2022 /PRNewswire/ — Rarecells, Inc. today announced the appointment of Dr. Neil Gunn, a recognized leader and expert in the diagnostic space, as an independent Board Director. “We are delighted to welcome Neil as Board Director. With his broad understanding of diagnostics and the Liquid Biopsy space he is well-positioned to provide valuable perspectives

We are delighted to join the prestigious The Oncology Think Tank, initiated by Prof. Azra Raza – Director of the MDS Center at Columbia University in New York, USA. We aim to provide patients with blood tests that diagnose cancer well before the moment medical imaging analyses are able to detect the tumor mass, making cancer

Attend the Keynote presentation ”New non-invasive approaches for early diagnosis and follow up of invasive cancers” of Prof. Patrizia Paterlini-Bréchot, CSO of Rarecells Diagnostics, during the 2nd Liquid Biopsies Congress, which will be held virtually and free to attend upon registration. Save the date: Thursday 2020, 08th October at 4:20 pm. For more information and

[OPPORTUNITY] – Rarecells is looking to hire a Research Lab Director! 🧬🦠🔬 For more info: www.rarecells.com/careers

Attend the Keynote presentation ” Clinical Applications of Circulating Tumor Cells in Predictive Oncology ” of Prof. Patrizia Paterlini-Bréchot, CSO of Rarecells Diagnostics, during the Circulating Biomarkers, Exosomes & Liquid Biopsy Europe 2019 Conference in Rotterdam. Save the date: Wednesday 2019, 30th October at 09:45 am. For more information visit: https://www.selectbiosciences.com/conferences/biographies.aspx?speaker=1472017&conf=EXLBPEU2019

https://actc2019.org Rarecells Diagnostics will be present at the 4th Advances in Circulating Tumor Cells congress, from 2 to 5 October 2019 in Corfu, Greece. We welcome you at our booth #4!